Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research | 最新消息 - 中國醫藥大學附設醫院

:::

院外單位健康通報

實名登記系統

最新消息

News & Message

:::

Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

最新消息

2025/2/5

Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research

作者群：郭倩宜(Chien-Yi Kuo)、林潔欣(Chieh-Hsin Lin)、藍先元(Hsien-Yuan Lane)*

期刊：CNS DRUGS

出版年月：2022

圖片來源：CNS DRUGS

連結：https://pubmed.ncbi.nlm.nih.gov/36194364/

回上頁

相關文章

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial

Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline

Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline

側邊開關圖示

中國醫點通